Chongqing Pharscin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China and internationally. It offers generic drugs, traditional Chinese medicines, and food for special medical purposes in various forms, including tablets, granules, capsules, soft capsules, powders, powder injections, lyophilized powder injections, small-volume injections, chemical raw materials, and traditional Chinese medicine extracts. The company is also involved in the provision of CDMO and CMO services; pharmaceutical technology development services and consulting; wholesale and retail activities; and scientific research and technical services. Its products are used in digestive diseases, central nervous system disorders, and otolaryngology therapeutic areas. The company was incorporated in 1996 and is headquartered in Chongqing, China.
Research context
Chongqing Pharscin Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Chongqing Pharscin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 5.4% below its 200 day moving average.
From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Chongqing Pharscin Pharmaceutical Co., Ltd's total revenue rose by 11.0% to $245M since the same quarter in the previous year.
Its net income has dropped by 30.0% to $32M since the same quarter in the previous year.
Finally, its free cash flow fell by 96.7% to $1M since the same quarter in the previous year.
Based on the above factors, Chongqing Pharscin Pharmaceutical Co., Ltd gets an overall score of 2/5.